Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G8BE
|
|||
| Former ID |
DIB004353
|
|||
| Drug Name |
AMPPL
|
|||
| Synonyms |
PYY-Fc-Leptin; PYY-Fc-Leptin fusion protein (diabetes/obesity), Amprotein
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Investigative | [1] | |
| Company |
AmProtein Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Leptin receptor (LEPR) | Target Info | Modulator | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Neuroactive ligand-receptor interaction | ||||
| AMPK signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| Adipocytokine signaling pathway | ||||
| Non-alcoholic fatty liver disease (NAFLD) | ||||
| Pathway Interaction Database | Signaling events mediated by PTP1B | |||
| WikiPathways | Leptin signaling pathway | |||
| AMPK Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1712). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.